Michael J. Hall, MD
Chair, Department of Clinical Genetics
Director, Gastrointestinal, genitourinary, and endocrine risk assessment
Hall specializes in cancers of the gastrointestinal (GI) tract, with a specific interest in pancreas, small bowel, and colon tumors. Dr. Hall's recent research has focused on the risk of pancreatic cancer in BRCA 1/2 mutation carriers, risk communication, racial/ethnic disparities in genetic testing, and the costs and benefits of pharmacogenomics, or the study of how genes affect a person's response to drugs, and other genetic testing in the treatment of cancer.
Mary B. Daly, MD, PhD, FACP
Timothy R. Talbot Jr. Chair for Cancer Research
A leader in cancer prevention and risk assessment at Fox Chase, Daly began one of the first risk assessment programs in the country in 1991 for people with a history of breast and/or ovarian cancer. Her primary areas of research include the epidemiologic and genetic aspects of breast and ovarian cancer, and the translation of this information into effective cancer prevention.
Your genetic counselor will review your medical and family history in order to determine the personal and inherited factors that could affect your risk of developing cancer. They will help you understand the influence of these different risk factors and help to coordinate genetic testing, if appropriate.
Hannah Campbell, ScM, LCGC
Hannah is a licensed and board-certified genetic counselor. Originally from Cheltenham, Hannah left the Philadelphia area to earn a degree in Cell and Molecular Biology from Connecticut College. After graduation, she joined the Lymphoma Clinical Trials group at Weill Cornell Medicine where she helped to coordinate treatment for patients on clinical drug trials, and collaborated on projects aimed at identifying risk factors for lymphoma. Hannah went on to receive my Masters in Genetic Counseling from the Johns Hopkins/ National Institutes of Health Genetic Counseling Program, where she recently completed her training.
Yael Frieberg, MS, LCGC
Yael is a licensed, board-certified genetic counselor. In 2015, she completed her B.S. in Biological Sciences with a minor in Gender Studies at the University of Southern California and then went on to receive her M.S. in Molecular Genetics and Biochemistry in 2016. She earned her M.S. in Genetic Counseling from the University of Pennsylvania in May of 2022. She then joined the Department of Clinical Genetics of Fox Chase Cancer Center in July of that year with goal of empowering patients by clarifying risks to themselves as well as family members and helping them understand their options for managing these risks and providing thoughtful, compassionate care and support at the time of visit.
Michelle McSweeny, MS, LCGC
McSweeny is a licensed and board-certified genetic counselor. She grew up in the Philadelphia area in Bucks County and began working in the Risk Assessment Program at Fox Chase in June 2014, after completing her master’s degree and several clinical internships at prominent medical centers in the region. In her multifaceted role at Fox Chase, McSweeny assesses candidates for genetic testing, explains the process so patients may make informed health decisions, and interprets testing results.
Catherine Neumann, MS, LCGC
Catie is a licensed and board-certified genetic counselor. She grew up in Bucks County, Pennsylvania and received her Bachelor of Science in Psychology from Lafayette College in Easton, Pennsylvania. After earning her undergraduate degree, Catie worked as a research assistant at Tufts Medical Center studying the genetic and environmental factors of macular degeneration and later as a research assistant at University of California Los Angeles for a clinical trial studying immunotherapy in patients with lung cancer. She went on to complete her Masters in Genetic Counseling at Boston University. Prior to starting at Fox Chase, she worked as a genetic counselor in Metabolic Genetics at Children’s Hospital of Orange County and in Cancer Genetics at St. Joseph Hospital in Orange, California.
Chau Q. Nguyen, CGC
Chau is a licensed and board-certified genetic counselor. She earned her undergraduate degree at the University of Delaware and obtained her Masters of Science in Genetic Counseling from Arcadia University. Prior to joining our Fox Chase team, she worked as a genetic counselor at Christiana Care Helen F. Graham Cancer Center & Research Institute. Chau’s focus is guiding patients and their family members to make informed decisions with regard to their personal and/or familial risk of cancer.
Corrine Zrada, MS, LCGC
Corinne is a licensed, board-certified genetic counselor. She completed her Masters of Science in Genetic Counseling at The University of Pennsylvania Perelman School of Medicine in Philadelphia in 2022. She joined the Department of Clinical Genetics in 2023 with focus on empowering patients to make informed health care decisions related to their personal risk of cancer.
Advanced Practice Clinicians
The Risk Assessment Program nurses perform a variety of roles in research and clinical care of high risks patients. The clinicians provide cancer risk assessment, education and counseling. They help evaluate family and medical history and, if appropriate, help coordinate genetic testing. The nurses also see patients in our high risk clinics for medical management, cancer screening and risk reduction.
Kathleen M. Henderson, MSN, ANP-BC
Genetic Nurse Practitioner
Kathy has worked her entire career in the oncology field since obtaining her BSN degree in 1992. She received her Master’s degree and Nurse Practitioner certification at the University of Pennsylvania. Throughout her career, she has valued her interactions with patients and colleagues, as well as the ongoing advancements in cancer treatment. In 2016, Kathy began working with the breast surgery team at Fox Chase in managing benign breast conditions and breast cancer survivors. In her current role with the Department of Clinical Genetics, she evaluates high-risk patients based on their personal medical history, family history of cancer, and genetic mutations. Kathy helps to guide these patients with high-risk screening and interventions to decrease cancer risk.
Devora Schapiro, MSPAS, PA-C
Devora is a licensed Physician Assistant in the states of PA and NJ. She completed her Bachelor of Arts in Genetics at Rutgers University and her Master of Science in Physician Assistant Studies at CUNY York College in Queens, NY. She joined the Department of Clinical Genetics in 2022, where she evaluates patients in the high-risk setting based on their personal or familial risk of cancer, offering screening recommendations accordingly.
Kathryn Tumelty, CRNP, FNP-C, AOCNP
Genetic Nurse Practitioner
Kathryn chose to work at Fox Chase when she relocated to the Philadelphia area in 2007 to continue her career in oncology at an academic cancer center. She had started her career at Duke University and wanted to continue to practice at a center that was dedicated to providing quality, up to the minute care. Kathryn spent over 10 years in the breast medical oncology department at Fox Chase working with women who were diagnosed with breast cancer. In 2018 she transitioned from medical oncology to the Department of Clinical Genetics and Risk Assessment. She now get to help patients in a high risk clinic before they are diagnosed with cancer with hopes of preventing it and guide those at an increased risk.
Maria Kadlec, BSN, RN
Genetic Nurse Navigator